Clinical Trials Browser

Pancreatic Intraductal Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT07253987 2026-04-17

SURV-QoL

Phase NA Recruiting

200 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07285993 2026-04-17

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

Phase 2 Recruiting

15 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT07287098 2026-04-17

preEMBER

Phase 2 Not yet recruiting

600 enrolled

Breast

Breast Neoplasms

NCT07294703 2026-04-17

Factors Associated With Breast Cancer Risks and Outcomes

Recruiting

750 enrolled

Breast

Breast Neoplasms

NCT07328516 2026-04-17

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Enrolling by invitation

64,277 enrolled

BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Breast Neoplasms, Leukemia, Melanoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT07400523 2026-04-17

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Phase 3 Recruiting

446 enrolled

Breast

Breast Neoplasms

NCT07504770 2026-04-17

Surgical Glove

Phase NA Not yet recruiting

84 enrolled

Breast

Breast Neoplasms

NCT07527806 2026-04-17

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

Phase 2 Not yet recruiting

156 enrolled

Breast

Breast Neoplasms

NCT07536815 2026-04-17

An Open-Label, Multicenter, Non-Randomized Expanded Access Protocol (EAP) Designed to Provide Leronlimab to Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer (mTNBC)

Available

Breast

Triple Negative Breast Neoplasms

NCT07536867 2026-04-17

SPSIP-RIB

Phase NA Not yet recruiting

50 enrolled

Breast

Breast Neoplasms, Pain, Postoperative

NCT07537712 2026-04-17

PPTOX-BC

Not yet recruiting

750 enrolled

Breast

Breast Neoplasms

NCT02744053 2026-04-16

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

96 enrolled

Breast

Triple Negative Breast Neoplasms

NCT02918474 2026-04-16

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Phase NA Recruiting

15 enrolled

Breast

Carcinoma, Intraductal, Noninfiltrating

NCT03157128 2026-04-16

LIBRETTO-001

Phase 1/2 Active not recruiting

857 enrolled 24 charts 6 FDA

BreastCNSEndocrineGastrointestinalHead & NeckThoracic

Thyroid Cancer, Papillary, Breast Neoplasms, Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Central Nervous System Neoplasms, Carcinoma, Medullary

NCT03377387 2026-04-16

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Phase 1/2 Active not recruiting

34 enrolled

Breast

Breast Neoplasms

NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

Phase 1 Active not recruiting

18 enrolled

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

Clinical Trials

METAL3

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors

ART

PREDICT

Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

InCITe

Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

ADARNAT

CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer

A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Quantitative MRI Assessment of Breast Cancer Therapy Response

Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

ANGEL

ECLECTIC

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

SENOVIE

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

CIPN

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

A Study of LY4175408 in Participants With Advanced Cancer

OMNIRAY

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment

TB06

FiREBOLT

SURV-QoL

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

preEMBER

Factors Associated With Breast Cancer Risks and Outcomes

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Surgical Glove

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

An Open-Label, Multicenter, Non-Randomized Expanded Access Protocol (EAP) Designed to Provide Leronlimab to Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer (mTNBC)

SPSIP-RIB

PPTOX-BC

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

LIBRETTO-001

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT